Datar Announces $250M Contract for Cancer Detection Liquid Biopsies
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | May 10, 2022 | Cancer, Company News |
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Cancer |
Research has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Lung Cancer |
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Cancer |
Foundation Medicine’s tissue-based test is a genomic profiling test approved as a companion diagnostic for a group of targeted therapies.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Cancer |
Deaths from cancer are expected to increase over the next decade due to screening deficits resulting from COVID-19 pandemic.
Read More